Literature DB >> 23098670

Functional expression of the damage-associated molecular pattern receptor P2X7 on canine kidney epithelial cells.

Iman Jalilian1, Mari Spildrejorde, Aine Seavers, Belinda L Curtis, Jason D McArthur, Ronald Sluyter.   

Abstract

Epithelial cells are important in inflammation and immunity. In this study, we examined if Madin-Darby canine kidney (MDCK) epithelial cells express functional P2X7 receptors, which bind the damage-associated molecular pattern extracellular adenosine 5'-triphosphate (ATP). Reverse transcription (RT)-PCR and immunoblotting revealed the expression of P2X7 in MDCK cells. A flow cytometric assay demonstrated that ATP or 2'(3')-O-(4-benzoylbenzoyl)ATP induced ethidium(+) uptake into MDCK cells, and that this process was impaired by the P2X7 antagonists KN-62 and A438079. RT-PCR also demonstrated the presence of Toll-like receptor 4, NALP3, caspase-1, interleukin-1β and interleukin-18 in MDCK cells, as well as in positive control LPS-primed canine monocytes. In conclusion, the MDCK epithelial cell line expresses functional P2X7, as well as Toll-like receptor 4 and molecules associated with the NALP3 inflammasome. This cell line may help elucidate the role of these molecules in kidney epithelial cells and renal disorders in dogs and humans.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098670     DOI: 10.1016/j.vetimm.2012.09.040

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 2.  The dark side of extracellular ATP in kidney diseases.

Authors:  Anna Solini; Vera Usuelli; Paolo Fiorina
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

Review 3.  Extracellular Nucleotides and P2 Receptors in Renal Function.

Authors:  Volker Vallon; Robert Unwin; Edward W Inscho; Jens Leipziger; Bellamkonda K Kishore
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

4.  Is the inflammasome a potential therapeutic target in renal disease?

Authors:  Clare M Turner; Nishkantha Arulkumaran; Mervyn Singer; Robert J Unwin; Frederick W K Tam
Journal:  BMC Nephrol       Date:  2014-01-23       Impact factor: 2.388

5.  Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Silvana Buccella; Valentina Di Liberto; Giuseppa Mudò; Natale Belluardo; Marzia Carluccio; Margherita Rossini; Daniele Filippo Condorelli; Michel Piers Rathbone; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Purinergic Signal       Date:  2017-06-14       Impact factor: 3.765

Review 6.  Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.

Authors:  Timothy M Fan; Kimberly A Selting
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

7.  Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.

Authors:  José Monteiro Sad Pereira; André Luis Barreira; Conrado Rodrigues Gomes; Felipe Mateus Ornellas; Débora Santos Ornellas; Luiz Carlos Miranda; Lucio Ronaldo Cardoso; Robson Coutinho-Silva; Alberto Schanaider; Marcelo M Morales; Maurilo Leite; Christina Maeda Takiya
Journal:  BMC Nephrol       Date:  2020-05-29       Impact factor: 2.388

8.  Emerging key roles for P2X receptors in the kidney.

Authors:  R E Birch; E M Schwiebert; C M Peppiatt-Wildman; S S Wildman
Journal:  Front Physiol       Date:  2013-09-27       Impact factor: 4.566

9.  P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis.

Authors:  Nishkantha Arulkumaran; Marije L Sixma; Sean Pollen; Elias Ceravola; Elisa Jentho; Maria Prendecki; Paul S Bass; Frederick W K Tam; Robert J Unwin; Mervyn Singer
Journal:  Physiol Rep       Date:  2018-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.